(Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (Q6)Jun 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 10.79%24.16B | 10.02%15.83B | 1.49%6.63B | -6.14%30.47B | -2.86%21.81B | -2.41%14.39B | -15.29%6.53B | 10.59%32.46B | 10.01%22.45B | 17.35%14.74B |
Operating income | 10.79%24.16B | 10.02%15.83B | 1.49%6.63B | -6.14%30.47B | -2.86%21.81B | -2.41%14.39B | -15.29%6.53B | 10.59%32.46B | 10.01%22.45B | 17.35%14.74B |
Operating expenses | -12.53%-17.81B | -15.58%-11.97B | -9.91%-5.29B | -5.09%-22.48B | -7.01%-15.83B | -6.79%-10.36B | 2.87%-4.81B | -18.61%-21.39B | -21.42%-14.79B | -26.50%-9.7B |
Gross profit | 6.21%6.36B | -4.27%3.86B | -22.04%1.34B | -27.85%7.99B | -21.91%5.99B | -20.08%4.03B | -37.59%1.72B | -2.21%11.07B | -6.88%7.67B | 3.02%5.05B |
Selling expenses | -0.97%-1.11B | 2.46%-691.7M | -10.44%-372.4M | -3.05%-1.37B | -2.27%-1.1B | -7.81%-709.13M | 39.11%-337.19M | 6.76%-1.33B | 22.36%-1.07B | 23.77%-657.76M |
Administrative expenses | -13.38%-1.3B | -10.82%-802.03M | -12.71%-396.97M | 3.19%-1.58B | -0.04%-1.14B | -6.77%-723.76M | 24.37%-352.19M | -1.87%-1.63B | -6.18%-1.14B | 6.52%-677.88M |
Research and development expenses | -181.31%-166.21M | -27.68%-58.34M | -49.22%-11.65M | -9.47%-78.16M | -102.78%-59.08M | -98.66%-45.69M | -27.19%-7.8M | -27.55%-71.4M | -77.51%-29.14M | -172.48%-23M |
Profit from asset sales | 341.81%6.97M | 525.43%5.31M | 27.29%-630.85K | -141.53%-7.16M | -63.38%-2.88M | 63.05%-1.25M | -153.76%-867.58K | 23.06%17.24M | -117.44%-1.76M | -137.48%-3.38M |
Revaluation surplus | -279.12%-37.04M | -333.94%-38.52M | -257.52%-40.06M | 522.41%18.99M | 194.08%20.68M | 227.54%16.47M | 380.37%25.43M | -286.90%-4.5M | -245.66%-21.98M | -73.37%-12.91M |
-Changes in the fair value of other assets | -279.12%-37.04M | -333.94%-38.52M | -257.52%-40.06M | 522.41%18.99M | 194.08%20.68M | 227.54%16.47M | 380.37%25.43M | -286.90%-4.5M | -245.66%-21.98M | -73.37%-12.91M |
Impairment and provision | 16.02%-52.71M | -10.50%-59.34M | -2,275.39%-9.75M | -115.73%-135.39M | -31.84%-62.76M | -45.17%-53.7M | 104.22%448.41K | 31.92%-62.76M | -23.09%-47.61M | -16.60%-36.99M |
-Other impairment is provision | 16.02%-52.71M | -10.50%-59.34M | -2,275.39%-9.75M | -115.73%-135.39M | -31.84%-62.76M | -45.17%-53.7M | 104.22%448.41K | 31.92%-62.76M | -23.09%-47.61M | -16.60%-36.99M |
Special items of operating profit | -4.23%178.79M | -5.21%113.09M | 84.51%70.35M | -0.21%234.46M | 5.19%186.68M | -15.30%119.3M | 4.12%38.13M | -34.36%234.96M | -37.73%177.46M | 0.67%140.85M |
Operating profit | -1.20%3.37B | -15.26%2.01B | -53.70%443.25M | -41.15%4.48B | -32.91%3.41B | -32.31%2.37B | -39.75%957.27M | -4.87%7.61B | -10.32%5.09B | 9.01%3.5B |
Financing cost | -45.08%-460.93M | -48.78%-245.24M | -19.05%-68.57M | -169.29%-458.49M | -166.68%-317.7M | -60.12%-164.83M | -255.79%-57.6M | 44.31%-170.26M | 18.36%-119.13M | -13.84%-102.94M |
Special items of earning before tax | -15.14%-30.31M | 38.13%-22.17M | 28.21%-11.63M | 51.68%-34.48M | -0.17%-26.32M | -115.72%-35.84M | -67.61%-16.2M | -102.19%-71.36M | 32.52%-26.28M | 51.41%-16.61M |
Earning before tax | -6.14%2.88B | -19.75%1.74B | -58.91%363.04M | -45.91%3.99B | -37.90%3.07B | -35.86%2.17B | -43.47%883.47M | -3.79%7.37B | -9.95%4.94B | 9.54%3.38B |
Tax | 2.31%-655.81M | 19.63%-388.32M | 56.00%-80.32M | 38.49%-964.53M | 35.79%-671.29M | 32.07%-483.16M | 45.37%-182.54M | -5.24%-1.57B | 0.91%-1.05B | -13.40%-711.28M |
After-tax profit from continuing operations | -7.21%2.22B | -19.78%1.35B | -59.66%282.72M | -47.91%3.02B | -38.47%2.4B | -36.87%1.68B | -42.96%700.93M | -5.97%5.8B | -12.10%3.89B | 8.55%2.67B |
Earning after tax | -7.21%2.22B | -19.78%1.35B | -59.66%282.72M | -47.91%3.02B | -38.47%2.4B | -36.87%1.68B | -42.96%700.93M | -5.97%5.8B | -12.10%3.89B | 8.55%2.67B |
Minority profit | 103.33%349.26M | 63.85%157.38M | 19.20%34.74M | -26.44%324.69M | -48.12%171.77M | -57.75%96.05M | -71.91%29.15M | -18.71%441.41M | -18.48%331.07M | 11.60%227.31M |
Profit attributable to shareholders | -15.75%1.87B | -24.85%1.19B | -63.09%247.98M | -49.68%2.7B | -37.57%2.22B | -34.92%1.59B | -40.29%671.78M | -4.74%5.36B | -11.46%3.56B | 8.27%2.44B |
Basic earnings per share | -15.89%0.9 | -24.68%0.58 | -62.50%0.12 | -49.61%1.3 | -37.79%1.07 | -34.75%0.77 | -40.74%0.32 | -4.09%2.58 | -10.88%1.72 | 9.26%1.18 |
Diluted earnings per share | -15.89%0.9 | -25.97%0.57 | -62.50%0.12 | -50.39%1.28 | -37.79%1.07 | -34.75%0.77 | -40.74%0.32 | -4.09%2.58 | -10.88%1.72 | 9.26%1.18 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data